KALA logo

Kala Pharmaceuticals (KALA) Shareholders Equity

Annual Shareholders Equity

$7.50 M
-$11.47 M-60.45%

31 December 2023

KALA Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Shareholders Equity

$6.86 M
-$6.86 M-50.00%

30 September 2024

KALA Quarterly Shareholders Equity Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

KALA Shareholders Equity Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-60.5%-38.9%
3 y3 years-92.5%-88.8%
5 y5 years-92.8%-84.1%

KALA Shareholders Equity High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-92.5%at low-88.8%+121.7%
5 y5 years-92.8%at low-95.2%+121.7%
alltimeall time-92.8%+108.5%-95.2%+106.4%

Kala Pharmaceuticals Shareholders Equity History

DateAnnualQuarterly
Sept 2024
-
$6.86 M(-50.0%)
June 2024
-
$13.72 M(+105.9%)
Mar 2024
-
$6.66 M(-11.2%)
Dec 2023
$7.50 M(-60.5%)
$7.50 M(-33.1%)
Sept 2023
-
$11.22 M(-35.8%)
June 2023
-
$17.49 M(-25.4%)
Mar 2023
-
$23.46 M(+23.6%)
Dec 2022
$18.97 M(+12.9%)
$18.97 M(-2060.1%)
Sept 2022
-
-$968.00 K(-96.9%)
June 2022
-
-$31.55 M(+497.2%)
Mar 2022
-
-$5.28 M(-131.4%)
Dec 2021
$16.80 M(-83.2%)
$16.80 M(-72.7%)
Sept 2021
-
$61.47 M(-27.1%)
June 2021
-
$84.27 M(-23.2%)
Mar 2021
-
$109.79 M(+9.8%)
Dec 2020
$100.00 M
$100.00 M(-5.7%)
DateAnnualQuarterly
Sept 2020
-
$106.03 M(-17.8%)
June 2020
-
$128.94 M(-8.9%)
Mar 2020
-
$141.51 M(+376.6%)
Dec 2019
$29.69 M(-71.7%)
$29.69 M(-31.0%)
Sept 2019
-
$43.06 M(-29.5%)
June 2019
-
$61.07 M(-25.9%)
Mar 2019
-
$82.37 M(-21.5%)
Dec 2018
$104.98 M(+17.1%)
$104.98 M(+91.1%)
Sept 2018
-
$54.93 M(-19.3%)
June 2018
-
$68.09 M(-15.2%)
Mar 2018
-
$80.27 M(-10.5%)
Dec 2017
$89.68 M(-202.2%)
$89.68 M(-9.3%)
Sept 2017
-
$98.86 M(-192.0%)
June 2017
-
-$107.42 M(-578.1%)
Mar 2017
-
$22.47 M(-125.6%)
Dec 2016
-$87.76 M(+54.9%)
-$87.76 M
Dec 2015
-$56.66 M
-

FAQ

  • What is Kala Pharmaceuticals annual stockholders equity?
  • What is the all time high annual shareholders equity for Kala Pharmaceuticals?
  • What is Kala Pharmaceuticals annual shareholders equity year-on-year change?
  • What is Kala Pharmaceuticals quarterly stockholders equity?
  • What is the all time high quarterly shareholders equity for Kala Pharmaceuticals?
  • What is Kala Pharmaceuticals quarterly shareholders equity year-on-year change?

What is Kala Pharmaceuticals annual stockholders equity?

The current annual shareholders equity of KALA is $7.50 M

What is the all time high annual shareholders equity for Kala Pharmaceuticals?

Kala Pharmaceuticals all-time high annual stockholders equity is $104.98 M

What is Kala Pharmaceuticals annual shareholders equity year-on-year change?

Over the past year, KALA annual stockholders equity has changed by -$11.47 M (-60.45%)

What is Kala Pharmaceuticals quarterly stockholders equity?

The current quarterly shareholders equity of KALA is $6.86 M

What is the all time high quarterly shareholders equity for Kala Pharmaceuticals?

Kala Pharmaceuticals all-time high quarterly stockholders equity is $141.51 M

What is Kala Pharmaceuticals quarterly shareholders equity year-on-year change?

Over the past year, KALA quarterly stockholders equity has changed by -$4.36 M (-38.88%)